Medication sector in Qatar: Hand in Hand Facing the blockade (9 – 10 March 2018)

Recent Submissions

  • Medication Sector in Qatar: Hand in Hand Facing the Blockade 

    Fakhro, Jassim; Al-Derham, Hassan; Diab, Mohammad; Al-Khal, Abdul Latif; Sulaiti, Ahmed; ... more authors (2018 , Conference)
    Conference agenda

  • National Strategic Stockpile for the Health Sector 

    Mohd, Alhajri (2018 , Presentation)
    Outline: - Introduction – Why Stockpile? National Strategic Stockpiles project (NSS) - Project Aim - Expected Outcomes - Proposal Process - Project Management Plan - Implementation steps - The blockade Challenges ...

  • Achieving Competence through an Informed Curriculum and Authentic Assessment 

    El Hajj, Maguy (2018 , Presentation)
    Learning Objectives: - List THREE ways in which health professional training and curriculum can address human capacity for blockade and emergency situations • Explain the role of academia for training of health professionals ...

  • Addressing Human Capacity Building for Health from Academia's Perspective : Building Interprofessional Partnership 

    El-Awaisi, Alla (2018 , Presentation)
    Learning objectives: – List strategies to increase readiness for emergency preparedness through interprofessional education and collaborative practice – List THREE benefits of interprofessional collaboration. – Explain ...

  • Addressing and sustaining human capital development for health through professional development in Qatar 

    Aboulsoud, Samar (2018 , Presentation)
    Outline: * Qatar Council for Healthcare Practitioners (QCHP) * QATAR VISION 2030 * National Health Strategy 2018-2022 *National CME/CPD Program in Numbers

  • Intellectual Property, Technology Transfer, and Local Production to Increase Access to Medicines 

    KATSIOLOUDES, MARIOS I. (2018 , Presentation)
    Outlines: * INTELLECTUAL PROPERTY (IP): THE CONCEPT *QATAR and IP * WIPO *QATAR’S OTHER MEMBERSHIPS *Patent Cooperation Treaty *INTELLECTUAL PROPERTY LAWS OF QATAR * TECHNOLOGY TRANSFER (TT) IN THE PHARMACEUTICAL ...

  • Supply of Medications and Patient Access to Different Therapies: HMC Experience 

    Al-Boloshi, Pharmacist Zakiya (2018 , Presentation)
    Outlines: • Drug supply aims and service . • Process of Ordering and Reordering of Medication in HMC. • HMC Formulary. • Medication Shortage . • Blockade and its Effects on Supplying of Medication.

  • Economic Opportunity: Brand Drugs vs. Generic Drugs 

    Al-Badriyeh, Daoud (2018 , Presentation)
    Outlines: * Pharmaceutical markets in the Middle East region are attractive *The high spending on branded drugs is unsustainable *Publicly funded health systems – increased pressure to reduce rising drug budgets *Originator ...

  • Pharmaceutical Industry in Qatar 

    Al-Mohannadi, Ahmed (2018 , Presentation)
    Overview: * Current Pharma Market Share of Qatar * Consequences of depending on other countries * Main challenges and barriers of local production of medicines in Qatar * How to overcome the challenges and barriers * ...

  • Generic Medicines: the big picture 

    Hassali, Mohamed Azmi Ahmad (2018 , Presentation)
    Outline: * BACKGROUND & INTRODUCTION * HEALTHCARE EXPENDITURE * ROLE OF GENERIC- MEDICINES IN HEALTH - CARE SYSTEM * GLOBAL SCENARIO * MALAYSIAN SCENARIO

  • The Right to Health under International Law 

    Konstantinidis, Ioannis (2018 , Presentation)
    Outline: * The International Legal Framework Surrounding the Right to Health * Key Aspects of the Right to Health * Obligations on States towards the Right to Health *Embargos and the Right to Health – Access to Medicines

  • Ensuring Access to Medicines in Qatar 

    Babiker, Ahmed Mohamed Hussein (2018 , Presentation)
    Summary & Conclusion: * Good healthcare system should ensure coverage, continuity, accessibility, quality and accountability during crisis as it was normal situation. * An efficient actions & crisis management with ...

  • WHO Model List Of Essential Medicines and countries Health response during Embargo 

    Alhajri, Mohd (2018 , Presentation)
    Outline: A. Challenges and barriers to medicines availability in crisis. B. Access to domestic and global market of generic medicines. C. WHO Model List Of Essential Medicines. D. Case example and the way forward from ...